Paul-Peter Tak
CEO & Board Director

Paul Peter Tak

Paul Peter Tak is a business leader, academic, entrepreneur and clinician who has over 30 years’ experience in medicine as a prominent expert in Immunology, Internal Medicine, and Rheumatology. Paul Peter is currently the President, CEO, and Board Director of Candel Therapeutics, the Co-Founder and Board Director of Sitryx Therapeutics, and Board Director of Levicept and Citryll.

Alongside his industry career, Paul Peter has dedicated much of his life to academia and advancing our understanding in medicine. He has served as Professor of Medicine at the University of Amsterdam and holds numerous honours for his service to medicine, with a special focus on Immunology and Rheumatology.

Candel Therapeutics is proud to share our recent achievements in the fight against cancer.
#CandelTherapeutics #viral #immunotherapy #vaccination #cancer #solid #tumor #pancreaticcancer #lungcancer
Candel Therapeutics Reports First Quarter 2024 Financial (http://globenewswire.com)

We are seeing steady advancement across our pipeline of clinical and preclinical programs and are excited for what’s to come. Learn about our Q1 progress and anticipated plans for the rest of the year in our Q1 2024 financial press release: https://bit.ly/44Ii9IH

Thank you, Arthur Franken, Nathalie ter Wengel, Kathereh Ahmadi, George Schragel and Nerida Scott for a great panel discussion about deal making at #BioEquity in San Sebastian! ⁦@CandelTx⁩

Load More
Paul Peter Tak

© Paul Peter Tak.
All rights reserved.